KR20140064906A - 에스트로겐 수용체 리간드 및 그의 이용 방법 - Google Patents

에스트로겐 수용체 리간드 및 그의 이용 방법 Download PDF

Info

Publication number
KR20140064906A
KR20140064906A KR1020147007549A KR20147007549A KR20140064906A KR 20140064906 A KR20140064906 A KR 20140064906A KR 1020147007549 A KR1020147007549 A KR 1020147007549A KR 20147007549 A KR20147007549 A KR 20147007549A KR 20140064906 A KR20140064906 A KR 20140064906A
Authority
KR
South Korea
Prior art keywords
compound
another embodiment
prostate cancer
crpc
castration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020147007549A
Other languages
English (en)
Korean (ko)
Inventor
제임스 달튼
미첼 에스. 스테이너
크리스토퍼 씨. 코스
Original Assignee
지티엑스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/215,679 external-priority patent/US9427418B2/en
Application filed by 지티엑스, 인코포레이티드 filed Critical 지티엑스, 인코포레이티드
Priority claimed from PCT/US2012/052141 external-priority patent/WO2013043304A1/en
Publication of KR20140064906A publication Critical patent/KR20140064906A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
KR1020147007549A 2011-08-23 2012-08-23 에스트로겐 수용체 리간드 및 그의 이용 방법 Withdrawn KR20140064906A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/215,679 US9427418B2 (en) 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof
US13/215,679 2011-08-23
PCT/US2012/052141 WO2013043304A1 (en) 2009-02-23 2012-08-23 Estrogen receptor ligands and methods of use thereof

Publications (1)

Publication Number Publication Date
KR20140064906A true KR20140064906A (ko) 2014-05-28

Family

ID=48444651

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147007549A Withdrawn KR20140064906A (ko) 2011-08-23 2012-08-23 에스트로겐 수용체 리간드 및 그의 이용 방법

Country Status (10)

Country Link
EP (1) EP2747562A4 (enExample)
JP (1) JP2014524479A (enExample)
KR (1) KR20140064906A (enExample)
CN (1) CN103957706A (enExample)
AU (1) AU2012312902B2 (enExample)
CA (1) CA2845890A1 (enExample)
IL (1) IL231070A0 (enExample)
IN (1) IN2014DN01959A (enExample)
MX (1) MX2014002105A (enExample)
RU (1) RU2014111060A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111164093A (zh) * 2017-09-27 2020-05-15 塔尔格免疫治疗有限公司 去势抵抗性前列腺癌
JP2022523094A (ja) * 2019-01-30 2022-04-21 アラゴン ファーマシューティカルズ，インコーポレイテッド 転移性去勢感受性前立腺癌の治療のための抗アンドロゲン剤
CN113853216A (zh) * 2019-02-01 2021-12-28 肿瘤学研究所基金会(Ior) 治疗去势抵抗性前列腺癌的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546451B2 (en) * 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
EA023472B1 (ru) * 2005-11-28 2016-06-30 Джи Ти Икс, ИНК. Агенты, связывающиеся с ядерными рецепторами
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
WO2010096801A1 (en) * 2009-02-23 2010-08-26 Gtx, Inc. Estrogen receptor ligands and methods of use thereof

Also Published As

Publication number Publication date
AU2012312902B2 (en) 2016-03-17
JP2014524479A (ja) 2014-09-22
MX2014002105A (es) 2014-09-25
CN103957706A (zh) 2014-07-30
CA2845890A1 (en) 2013-03-28
RU2014111060A (ru) 2015-09-27
IN2014DN01959A (enExample) 2015-05-15
EP2747562A4 (en) 2015-05-06
IL231070A0 (en) 2014-03-31
EP2747562A1 (en) 2014-07-02
AU2012312902A1 (en) 2013-05-23

Similar Documents

Publication Publication Date Title
KR101458539B1 (ko) 에스트로겐 수용체 리간드 및 그 이용 방법
US9051267B2 (en) Estrogen receptor ligands and methods of use thereof
AU2006318400B2 (en) Nuclear receptor binding agents
US20140187641A1 (en) Estrogen receptor ligands and methods of use thereof
CN110840870A (zh) 选择性雄激素受体调节剂在治疗转移性和难治性乳癌中的应用
US9427418B2 (en) Estrogen receptor ligands and methods of use thereof
US9409856B2 (en) Estrogen receptor ligands and methods of use thereof
KR20140064906A (ko) 에스트로겐 수용체 리간드 및 그의 이용 방법
US9624161B2 (en) Estrogen receptor ligands and methods of use thereof
US20140057985A1 (en) Estrogen receptor ligands and methods of use thereof
US20140057946A1 (en) Estrogen receptor ligands and methods of use thereof
WO2013043304A1 (en) Estrogen receptor ligands and methods of use thereof
AU2010215809B2 (en) Estrogen receptor ligands and methods of use thereof
AU2011226856B2 (en) Nuclear receptor binding agents

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000